NATHAN HOWARD: Open Payments
NPI 1104449024 · ROYAL PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 24 payments from 9 companies in 2025. Trend: 2023 $718 · 2024 $1,823 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $165 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 3 | $84 |
| Teva Pharmaceuticals USA, Inc. | 2 | $68 |
| Alkermes, Inc. | 3 | $60 |
| Corium, LLC | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: VRAYLAR, REXULTI, SPRAVATO, AUSTEDO XR, LYBALVI, Azstarys, INGREZZA, COBENFY.
Industry payments across FL — which companies pay providers there.
